Boston Scientific and Edwards Lifesciences are set to report third-quarter earnings this week that may continue to signal a recovery in medtech procedure volumes.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,